Longevity Drug
Senolytic Protocols Clinics
Intermittent dosing of senolytic compounds (dasatinib + quercetin, fisetin) intended to clear senescent cells.
About Senolytic Protocols
Senolytics aim to selectively clear senescent cells, a cell type that accumulates with age and secretes pro-inflammatory factors. The animal evidence is striking; the human evidence is early-stage, with small open-label trials in idiopathic pulmonary fibrosis and diabetic kidney disease showing signals worth pursuing in larger trials. Most clinic protocols use dasatinib + quercetin pulses or fisetin, dosed intermittently rather than daily.